Testing inhomogeneous solvation theory in structure-based ligand discovery

被引:56
|
作者
Balius, Trent E. [1 ]
Fischer, Marcus [1 ,7 ,8 ]
Stein, Reed M. [2 ]
Adler, Thomas B. [1 ]
Nguyen, Crystal N. [3 ]
Cruz, Anthony [4 ,5 ]
Gilson, Michael K. [3 ]
Kurtzman, Tom [4 ,5 ,6 ]
Shoichet, Brian K. [1 ]
机构
[1] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA
[2] Univ Calif San Francisco, Grad Program Pharmaceut Sci & Pharmacogen, San Francisco, CA 94158 USA
[3] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[4] Lehman Coll, Dept Chem, Bronx, NY 10468 USA
[5] CUNY, Grad Ctr, PhD Program Chem, New York, NY 10016 USA
[6] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10016 USA
[7] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 332 N Lauderdale St, Memphis, TN 38105 USA
[8] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA
基金
美国国家卫生研究院;
关键词
water; inhomogeneous solvation theory; ligand discovery; structure-based drug design; docking; MOLECULAR-DYNAMICS; FREE-ENERGIES; ACTIVE-SITE; WATER-MOLECULES; THERMODYNAMIC CONTRIBUTIONS; FLUID APPROACH; BINDING-SITE; SOLVENT; DOCKING; FLEXIBILITY;
D O I
10.1073/pnas.1703287114
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Binding-site water is often displaced upon ligand recognition, but is commonly neglected in structure-based ligand discovery. Inhomogeneous solvation theory (IST) has become popular for treating this effect, but it has not been tested in controlled experiments at atomic resolution. To do so, we turned to a grid-based version of this method, GIST, readily implemented in molecular docking. Whereas the term only improves docking modestly in retrospective ligand enrichment, it could be added without disrupting performance. We thus turned to prospective docking of large libraries to investigate GIST's impact on ligand discovery, geometry, and water structure in a model cavity site well-suited to exploring these terms. Although top-ranked docked molecules with and without the GIST term often overlapped, many ligands were meaningfully prioritized or deprioritized; some of these were selected for testing. Experimentally, 13/14 molecules prioritized by GIST did bind, whereas none of the molecules that it deprioritized were observed to bind. Nine crystal complexeswere determined. In six, the ligand geometry corresponded to that predicted by GIST, for one of these the pose without the GIST term was wrong, and three crystallographic poses differed fromboth predictions. Notably, in one structure, an ordered water molecule with a high GIST displacement penalty was observed to stay in place. Inclusion of this water-displacement term can substantially improve the hit rates and ligand geometries from docking screens, although the magnitude of its effects can be small and its impact in drug binding sites merits further controlled studies.
引用
收藏
页码:E6839 / E6846
页数:8
相关论文
共 50 条
  • [31] Structure-based ligand design and discovery of novel tenuazonic acid derivatives with high herbicidal activity
    Wang, He
    Yao, Qin
    Guo, Yanjing
    Zhang, Qian
    Wang, Zhongchang
    Strasser, Reto Joerg
    Valverde, Bernal E.
    Chen, Shiguo
    Qiang, Sheng
    Kalaji, Hazem M.
    JOURNAL OF ADVANCED RESEARCH, 2022, 40 : 29 - 44
  • [32] MISATO: machine learning dataset of protein-ligand complexes for structure-based drug discovery
    Siebenmorgen, Till
    Menezes, Filipe
    Benassou, Sabrina
    Merdivan, Erinc
    Didi, Kieran
    Mourao, Andre Santos Dias
    Kitel, Radoslaw
    Lio, Pietro
    Kesselheim, Stefan
    Piraud, Marie
    Theis, Fabian J.
    Sattler, Michael
    Popowicz, Grzegorz M.
    NATURE COMPUTATIONAL SCIENCE, 2024, 4 (05): : 367 - 378
  • [33] Fragment approaches in structure-based drug discovery
    Hubbard, Roderick E.
    JOURNAL OF SYNCHROTRON RADIATION, 2008, 15 (227-230) : 227 - 230
  • [34] Structure-based discovery of nonhallucinogenic psychedelic analogs
    Cao, Dongmei
    Yu, Jing
    Wang, Huan
    Luo, Zhipu
    Liu, Xinyu
    He, Licong
    Qi, Jianzhong
    Fan, Luyu
    Tang, Lingjie
    Chen, Zhangcheng
    Li, Jinsong
    Cheng, Jianjun
    Wang, Sheng
    SCIENCE, 2022, 375 (6579) : 403 - +
  • [35] Structure-based drug discovery for Plasmodium falciparum
    Mehlin, C
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2005, 8 (01) : 5 - 14
  • [36] New Targets for Structure-Based Drug Discovery
    Andrews, Steve
    Congreve, Miles
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (01) : 2 - 3
  • [37] Structure-Based Drug Discovery with Deep Learning
    Ozcelik, R.
    van Tilborg, D.
    Jimenez-Luna, J.
    Grisoni, F.
    CHEMBIOCHEM, 2023,
  • [38] Structure-Based Drug Discovery for Botulinum Neurotoxins
    Swaminathan, Subramanyam
    BOTULINUM NEUROTOXINS, 2013, 364 : 197 - 218
  • [39] Needle in the haystack: structure-based toxin discovery
    Fieldhouse, Robert J.
    Merrill, A. Rod
    TRENDS IN BIOCHEMICAL SCIENCES, 2008, 33 (11) : 546 - 556
  • [40] Structure-based screening and design in drug discovery
    van Dongen, M
    Weigelt, J
    Uppenberg, J
    Schultz, J
    Wikström, M
    DRUG DISCOVERY TODAY, 2002, 7 (08) : 471 - 478